RHYTHM PHARMACEUTICALS, INC. (31)

Browse by Contract Category

Contracts

Underwriting Agreement, dated as of September 14, 2022, between Rhythm Pharmaceuticals, Inc. and Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo... (Filed With SEC on September 15, 2022)
Revenue Interest Financing Agreement, dated June 16, 2022, by and between the Company and entities managed by HealthCare Royalty Management, LLC (Filed With SEC on August 3, 2022)
Consulting Agreement, dated September 11, 2021, by and between the Registrant and Murray Stewart, D.M., F.R.C.P (Filed With SEC on March 1, 2022)
License Agreement, dated December 3, 2021, by and between the Registrant and RareStone Group Ltd (Filed With SEC on March 1, 2022)
Offer Letter, dated September 1, 2021, by and between the Registrant and Linda Shapiro Manning, M.D (Filed With SEC on November 2, 2021)
First Amendment to Lease, dated April 15, 2016 (Filed With SEC on March 8, 2019)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2022)
2022 Employment Inducement Plan Form of Restricted Stock Unit Agreement (Filed With SEC on March 1, 2022)
2022 Employment Inducement Plan and Form of Option Agreement (Filed With SEC on March 1, 2022)
Amendment No. 1 to Amended and Restated Investors Rights Agreement, dated January 25, 2021 (Filed With SEC on November 2, 2021)
Offer Letter, dated July 9, 2021, by and between the Registrant and Pamela Cramer (Filed With SEC on August 3, 2021)
Offer Letter, dated September 25, 2020, by and between the Registrant and Jennifer Chien (Filed With SEC on March 1, 2021)
Offer Letter, dated September 14, 2018, by and between the Registrant and Murray Stewart M.D (Filed With SEC on March 1, 2021)
Offer Letter, dated May 10, 2018, by and between the Registrant and Simon D. Kelner (Filed With SEC on March 1, 2021)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2021)
Underwriting Agreement, dated as of February 4, 2021, between Rhythm Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Cowen and Company, LLC and Stifel,... (Filed With SEC on February 5, 2021)
Asset Purchase Agreement, dated as of January 5, 2021, by and between Rhythm Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc (Filed With SEC on January 5, 2021)
Separation Agreement, dated September 30, 2020, between Rhythm Pharmaceuticals, Inc. and Nithya Desikan (Filed With SEC on November 2, 2020)
Offer Letter, dated September 4, 2020, and Indefinite Term Employment Contract, dated October 5, 2020, between Rhythm Pharmaceuticals, Inc. and Yann Mazabraud (Filed With SEC on November 2, 2020)
Amendment No. 2 to Development and Manufacturing and Services Agreement, dated as of July 15, 2020, by and between the Company and Corden Pharma Brussels S.A (Filed With SEC on August 3, 2020)
Offer Letter, dated July 16, 2020, between Rhythm Pharmaceuticals, Inc. and David P. Meeker, M.D (Filed With SEC on July 21, 2020)
Amendment No. 1 to Development and Manufacturing and Services Agreement, dated as of February 20, 2020, by and between the Company and Corden Pharma Brussels S.A (Filed With SEC on May 4, 2020)
Offer Letter, dated December 21, 2017, by and between the Company and Hunter C. Smith (Filed With SEC on May 4, 2020)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on May 4, 2020)
Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 2, 2020)
Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2020)
Consulting Agreement dated January 6, 2020 (Filed With SEC on January 8, 2020)
Separation Agreement and General Release dated January 6, 2020 (Filed With SEC on January 8, 2020)
Underwriting Agreement dated October 15, 2019 (Filed With SEC on October 16, 2019)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on July 25, 2019)
Offer Letter, dated September 13, 2017, by and between the Registrant and Lex H.T. Van der Ploeg (Filed With SEC on March 8, 2019)